Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Celerion announced the expansion of its bioanalytical laboratory in Zurich, Switzerland. The investment strengthens Celerion’s ability to support increasing global demand for bioanalytical services, providing clients with enhanced capacity, rapid ...
read more
Orphan Therapeutics Accelerator has expanded its Orphan ClinDevNet development network with four new strategic partners—OPIS, Uniphar, SK pharmteco and TMC Pharma—to strengthen end-to-end support for ultra-rare disease therapies.
read more
Shilpa Biologicals announced the commissioning of a state-of-the-art Antibody–Drug Conjugate (ADC) GMP manufacturing facility, purpose-built and designed to meet global regulatory approval standards including US FDA, EMA, and other major health ...
read more
WuXi Biologics said its MFG17 drug substance facility at the Shanghai Fengxian site has successfully completed its first GMP production campaign, with manufacturing executed without any deviations.
read more
The FDA is rolling out a series of reforms intended to accelerate and modernize clinical research across the full continuum of drug development, from pre IND interactions through late stage pivotal trials.
read more
Sartorius and LFB BIOMANUFACTURING have expanded their collaboration to provide biopharmaceutical clients with an integrated service offering that spans from cell line development (CLD) through to the first GMP drug substance batch.
read more
Sanner is rebranding its subsidiaries under a single Sanner Group umbrella, beginning with the transition of UK-based Springboard to Sanner UK.
read more
Piramal Pharma Solutions (PPS) said it completed more than 200 customer audits and secured over 70 regulatory approvals across its global network over the past fiscal year.
read more
Minaris announced the enhancement of its dedicated GMP cell banking suites at its Philadelphia facility, a centralized hub for cell banking and biosafety testing.
read more
WuXi Biologics announced that its Biosafety Testing Center in Suzhou has successfully passed a Good Manufacturing Practice (GMP) inspection by the European Medicines Agency (EMA) with zero critical findings.
read more
Alcami Corporation announced a series of strategic and operational investments at its Tennessee facility, which was recently added to the company’s network through its acquisition of Tjoapack.
read more
Mabion S.A., a Polish biotechnology company, has signed a letter of intent (LoI) with French TechDev company Oddifact SAS to evaluate and advance MabionCD20 for potential use in rare diseases.
read more
CCRM and its CDMO subsidiary OmniaBio announced an agreement with Avectas Limited to evaluate its automated, integrated and scalable cell therapy manufacturing platform.
read more
VIVEbiotech announced the addition of its 15th in vivo lentiviral vector-based therapeutic program using its well-established platform.
read more
Neuland Laboratories will open a dedicated process development laboratory and integrated kilo lab at its Genome Valley campus in Hyderabad.
read more